Younge Noelle, Patel Ravi M
Department of Pediatrics, Duke University, 2400 Pratt Street, DUMC Box 2739, Durham, NC 27705, USA.
Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Arthur M. Blank Hospital, 2220 North Druid Hills Road NE, CL.06323, Atlanta, GA 30329, USA.
Clin Perinatol. 2025 Mar;52(1):87-100. doi: 10.1016/j.clp.2024.10.006. Epub 2024 Nov 27.
Probiotic use has increased in preterm infants and may reduce the risk of necrotizing enterocolitis. Probiotic-associated infection is a concern for infants receiving probiotic supplementation in the neonatal intensive care unit, as highlighted by a recent case and subsequent action by the United States Food and Drug Administration. Based on reports to date, invasive infection is an infrequent but known risk of probiotic supplementation. In this article, we discuss the epidemiology and pathophysiology of invasive infection in preterm infants, review the benefits and risks of probiotic as regulations and available products continue to evolve.
益生菌在早产儿中的使用有所增加,可能会降低坏死性小肠结肠炎的风险。如最近的一个病例以及美国食品药品监督管理局随后采取的行动所强调的那样,益生菌相关感染是新生儿重症监护病房中接受益生菌补充剂的婴儿所面临的一个问题。根据迄今为止的报告,侵袭性感染是益生菌补充剂一种虽不常见但已知的风险。在本文中,我们讨论早产儿侵袭性感染的流行病学和病理生理学,随着法规和现有产品的不断发展,回顾益生菌的益处和风险。